BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2637044)

  • 1. Recognition in cell adhesion. A comparative study of the conformations of RGD-containing peptides by Monte Carlo and NMR methods.
    Cachau RE; Serpersu EH; Mildvan AS; August JT; Amzel LM
    J Mol Recognit; 1989 Dec; 2(4):179-86. PubMed ID: 2637044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Conformational analysis of biologically active RGD-containing cyclopentapeptides].
    Kostetskiĭ PV; Artem'ev IV
    Bioorg Khim; 2000 Apr; 26(4):290-8. PubMed ID: 10857021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The aqueous conformation of cyclo(1,6)Ac-Cys-Arg-Gly-Asp-Phe-Pen-NH2.
    Siahaan TJ; Bruss D; Powell NA; Chakrabarti S; Conrad M
    Int J Pept Protein Res; 1994 Nov; 44(5):427-34. PubMed ID: 7896500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclic pentapeptides as models for reverse turns: determination of the equilibrium distribution between type I and type II conformations of Pro-Asn and Pro-Ala beta-turns.
    Stradley SJ; Rizo J; Bruch MD; Stroup AN; Gierasch LM
    Biopolymers; 1990 Jan; 29(1):263-87. PubMed ID: 2328290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptide inhibitors of fibronectin, laminin, and other adhesion molecules: unique and shared features.
    Yamada KM; Kennedy DW
    J Cell Physiol; 1987 Jan; 130(1):21-8. PubMed ID: 3805128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conformation/activity studies of rationally designed potent anti-adhesive RGD peptides.
    Gurrath M; Müller G; Kessler H; Aumailley M; Timpl R
    Eur J Biochem; 1992 Dec; 210(3):911-21. PubMed ID: 1483474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arg-Gly-Asp constrained within cyclic pentapeptides. Strong and selective inhibitors of cell adhesion to vitronectin and laminin fragment P1.
    Aumailley M; Gurrath M; Müller G; Calvete J; Timpl R; Kessler H
    FEBS Lett; 1991 Oct; 291(1):50-4. PubMed ID: 1718779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preferred conformations of RGDX tetrapeptides to inhibit the binding of fibrinogen to platelets.
    Park HS; Kim C; Kang YK
    Biopolymers; 2002 Apr; 63(5):298-313. PubMed ID: 11877740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conformational study of cyclo(1,5)-Ac-Pen-Arg-Gly-Asp-Cys-NH2 in water by NMR and molecular dynamics.
    Siahaan TJ; Chakrabarti S; Vander Velde D
    Biochem Biophys Res Commun; 1992 Sep; 187(2):1042-7. PubMed ID: 1530602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta VI turns in peptides and proteins: a model peptide mimicry.
    Müller G; Gurrath M; Kurz M; Kessler H
    Proteins; 1993 Mar; 15(3):235-51. PubMed ID: 8456095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of conformational equilibrium of peptides in solution by NMR spectroscopy and theoretical conformational analysis: application to the calibration of mean-field solvation models.
    Groth M; Malicka J; Rodziewicz- Motowidło S; Czaplewski C; Klaudel L; Wiczk W; Liwo A
    Biopolymers; 2001; 60(2):79-95. PubMed ID: 11455544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional analysis and modeling of a conformationally constrained Arg-Gly-Asp sequence inserted into human lysozyme.
    Yamada T; Uyeda A; Kidera A; Kikuchi M
    Biochemistry; 1994 Oct; 33(39):11678-83. PubMed ID: 7522552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation and characterization of specific antibodies directed to the binding domain of adhesive molecules.
    Berliner SA; Roberts JR; Thorn ML; Ruggeri ZM
    Pept Res; 1988; 1(2):60-4. PubMed ID: 2485226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biologically active Arg-Gly-Asp oligopeptides assume a type II beta-turn in solution.
    Johnson WC; Pagano TG; Basson CT; Madri JA; Gooley P; Armitage IM
    Biochemistry; 1993 Jan; 32(1):268-73. PubMed ID: 8418846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced conformational sampling in Monte Carlo simulations of proteins: application to a constrained peptide.
    Kidera A
    Proc Natl Acad Sci U S A; 1995 Oct; 92(21):9886-9. PubMed ID: 7568238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of vitronectin receptor-mediated osteoclast adhesion by Arg-Gly-Asp peptide analogs: a structure-function analysis.
    Horton MA; Dorey EL; Nesbitt SA; Samanen J; Ali FE; Stadel JM; Nichols A; Greig R; Helfrich MH
    J Bone Miner Res; 1993 Feb; 8(2):239-47. PubMed ID: 7680185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solution conformation of a model hexapeptide containing RGD sequence.
    Dhingra MM
    Indian J Biochem Biophys; 1992 Dec; 29(6):458-64. PubMed ID: 1294461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anti-adhesive and anti-thrombotic effects of integrin-inhibiting tripeptides (Arg-Gly-Asp)].
    Udvardy M
    Orv Hetil; 1995 Oct; 136(40):2155-9. PubMed ID: 7566948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary structure of the Arg-Gly-Asp recognition site in proteins involved in cell-surface adhesion. Evidence for the occurrence of nested beta-bends in the model hexapeptide GRGDSP.
    Reed J; Hull WE; von der Lieth CW; Kübler D; Suhai S; Kinzel V
    Eur J Biochem; 1988 Dec; 178(1):141-54. PubMed ID: 3203684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclic RGD peptidomimetics containing bifunctional diketopiperazine scaffolds as new potent integrin ligands.
    Marchini M; Mingozzi M; Colombo R; Guzzetti I; Belvisi L; Vasile F; Potenza D; Piarulli U; Arosio D; Gennari C
    Chemistry; 2012 May; 18(20):6195-207. PubMed ID: 22517378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.